Company Data
Ambrx Biopharma Inc.
Ticker
AMAM
Current Price
$14.01 -0.14%
Market Cap
$5.4B
Price Target
Refer to Report
Volume
478.9K
52wk Range
$0.38 - $15.29
Overview
Ambrx Inc., is a clinical-stage biopharmaceutical company focused on developing Precision Biologics using an expanded genetic code. Ambrx technology uses an expanded genetic code to incorporate synthetic amino acids into protein, all completed within a living cell. These synthetic amino acids enable the creation of Precision Biologics, an exciting new class of therapeutics with broad application and potential. This includes next-generation antibody drug conjugates (ADCs), bispecifics, and targeted immuno-oncology therapies for cancer as well as smart cytokines to modulate the immune system, and long-acting therapeutic peptides for metabolic and cardiovascular disease.